Status
Conditions
Treatments
About
NBCA is a synthetic biodegradable cyanoacrylate basis glue, modified by the addition of a monomer with adhesive, hemostatic, and antiseptic properties.
Its use requires a steep learning curve to control emulsification of the NBCA/lipiodol mixture, and injection, to avoid non-target embolization.
The aim of this retrospective monocentric study was to evaluate safety and efficacy of use of NBCA as embolic agent in emergency setting.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
122 participants in 1 patient group
Loading...
Central trial contact
Rémi GRANGE, MD; Sylvain GRANGE, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal